Status:

COMPLETED

Effect of Maraviroc on Endothelial Function in HIV-Infected Patients

Lead Sponsor:

University of California, San Francisco

Collaborating Sponsors:

National Heart, Lung, and Blood Institute (NHLBI)

Pfizer

Conditions:

HIV Infection

Cardiovascular Disease

Eligibility:

All Genders

18+ years

Phase:

PHASE3

Brief Summary

The purpose of this study is to determine the potentially beneficial aspects of CCR5 inhibition on inflammation and endothelial function as measured by brachial artery reactivity in antiretroviral tre...

Eligibility Criteria

Inclusion

  • Stable antiretroviral therapy for at least 12 months
  • All plasma HIV RNA levels within the past year must be below level of detection (\< 50 copies RNA/mL), although isolated single values \> 50 but \< 200 copies will be allowed.
  • Screening plasma HIV RNA levels \< 50 copies RNA/mL
  • \>90% adherence to therapy within the preceding 30 days, as determined by self-report
  • Females of childbearing potential must have a negative serum pregnancy test at screening and agree to use a double-barrier method of contraception throughout the study period.

Exclusion

  • Ongoing or prior use of any integrase inhibitor or R5 inhibitor.
  • Patients who plan to modify existing antiretroviral therapy in the next 24 weeks for any reason
  • Serious illness requiring hospitalization or parental antibiotics within preceding 3 months
  • Concurrent or recent exposure to any immunomodulatory drugs
  • Advanced liver disease or active hepatitis B or C
  • Patients with systolic blood pressure \<100/70
  • Starting or stopping statin therapy during the trial

Key Trial Info

Start Date :

January 1 2010

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

June 1 2014

Estimated Enrollment :

52 Patients enrolled

Trial Details

Trial ID

NCT00844519

Start Date

January 1 2010

End Date

June 1 2014

Last Update

July 24 2014

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of California, San Francisco

San Francisco, California, United States, 94110

Effect of Maraviroc on Endothelial Function in HIV-Infected Patients | DecenTrialz